Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on rifampin drug interactions, III

V A Strayhorn1, A M Baciewicz, T H Self

  • 1Department of Clinical Pharmacy, University of Tennessee, Memphis, USA.

Archives of Internal Medicine
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical management.

Journal of clinical pharmacy and therapeutics·2017
Same author

Are there gender differences in the use of peak flow meters?

The Journal of asthma : official journal of the Association for the Care of Asthma·2001
Same author

Bleeding associated with doxycycline and warfarin treatment.

Archives of internal medicine·2001
Same author

Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

Drugs·2001
Same author

Studies demonstrating improved outcomes in patients with asthma: a 10-year review.

The American journal of managed care·2001
Same author

Hospital admission due to warfarin potentiation by TMP-SMX.

The Nurse practitioner·2001

Rifampin significantly interacts with many medications by inducing cytochrome P-450 enzymes. Clinicians must understand these drug interactions to prevent treatment failure or adverse events.

Area of Science:

  • Pharmacology
  • Drug Metabolism

Background:

  • Rifampin is a widely used antibiotic known to strongly induce cytochrome P-450 (CYP450) oxidative enzymes.
  • CYP450 enzymes play a crucial role in the metabolism of numerous medications.

Purpose of the Study:

  • To summarize known and emerging drug-drug interactions involving rifampin.
  • To highlight the clinical significance of these interactions for healthcare providers.

Main Methods:

  • Review of documented clinical interactions between rifampin and other drugs.
  • Analysis of recent reports on rifampin-related drug interactions.

Main Results:

  • Rifampin is a potent inducer of CYP450 enzymes, affecting numerous drugs.
  • Well-documented interactions include warfarin, oral contraceptives, cyclosporine, and theophylline.

Related Experiment Videos

  • Recent reports indicate interactions with protease inhibitors, antiretrovirals (e.g., zidovudine), antifungals (e.g., itraconazole), and various other medications.

    • Conclusions:

    • Clinicians must be aware of rifampin's interaction potential to avoid therapeutic failure or toxicity.
    • Continued research is needed to fully elucidate rifampin's effects on specific CYP450 isoenzymes and discover new interactions.